Buscar

Mostrando ítems 1-10 de 76

Development of a new bombesin analog radiolabelled with lutetium-177: in vivo evaluation of the biological properties in BALB-C mice

PUJATTI, P.B.; SANTOS, J.S.; MASSICANO, A.V.F.; MENGATTI, J.; ARAUJO, E.B. de (2010)

Radiolabeling of substance p with lutetium-177 and biodistribution study in rat pancreatic tumor xenografted nude mice

ARAUJO, E.B. de; PUJATTI, P.B.; MENGATTI, J. (2010)

On the feasibility of producing Lu-177 in the IEA-R1 reactor via the direct route

GENEZINI, FREDERICO A.; ZAHN, GUILHERME S.; SILVA, PAULO S.C. da; NORY, RENATA M.; MOREIRA, EDSON G.; SANTIAGO, PAULO S.; INTERNATIONAL NUCLEAR ATLANTIC CONFERENCE (Associa????o Brasileira de Energia Nuclear, 2020)

On the feasibility of producing Lu-177 in the IEA-R1 reactor via the direct route

ZAHN, G.S.; GENEZINI, F.A.; SILVA, P.S.C.; NORY, R.M.; MOREIRA, E.G.; SANTIAGO, P.S. (2021)

Radiolabeling of anti-cd20 with Re-188: liquid kit

DIAS, CARLA R.; OSSO JUNIOR, JOAO A.; INTERNATIONAL NUCLEAR ATLANTIC CONFERENCE; MEETING ON NUCLEAR APPLICATIONS, 8th/ MEETING ON REACTOR PHYSICS AND THERMAL HYDRAULICS, 15th (Sao Paulo: ABEN, 2007, 2014)

Lutetium 177-DOTA-TATE therapy for esthesioneuroblastoma: A case report

Med Ctr Sorocaba; Barretos Canc Hosp; Dr Ary Pinheiro Base Hosp; Universidade Estadual Paulista (Unesp) (Spandidos Publ Ltd, 2016-11-01)

Esthesioneuroblastoma (ENB), also known as olfactory neuroblastoma, is a rare malignant tumor that accounts for 3% of all tumors of the nasal cavity. The incidence of ENB is 0.4 cases per million in the general population, ...

In vitro and in vivo response of PSMA-617 radiolabeled with CA and NCA lutetium-177

BOAS, CRISTIAN A.W.V.; SILVA, JEFFERSON de J.; DIAS, LUIS A.P.; FREIRE, MARIA R.B.; BALIEIRO, LUIZA M.; SANTOS, CAROLINA S.F. dos; VIVALDINI, BIANCA F.; BENEDETTO, RAQUEL; VIEIRA, DANIEL P.; PASSOS, PRISCILA de Q.S.; MARUMO, MARIA H.; TEIXEIRA, LUIS F.S.; ARAUJO, ELAINE B. de (2022)

In vitro response of 177Lu-PSMA-617 with two different specific activities

VILLAS BOAS, CRISTIAN A.W.; MENGATTI, JAIR; PASSOS, PRISCILA; VIEIRA, DANIEL; ARAUJO, ELAINE B. de (2020)

Study of the radiolabeling of substance P with lutetium 177 and analysis of the stability In Vitro: development of new radiopharmaceutical for tumor treatment

LIMA, CLARICE M.; PUJATTI, PRISCILLA B.; MENGATTI, JAIR; ARAUJO, ELAINE B.; INTERNATIONAL NUCLEAR ATLANTIC CONFERENCE; MEETING ON NUCLEAR APPLICATIONS, 9th; MEETING ON REACTOR PHYSICS AND THERMAL HYDRAULICS, 16th; MEETING ON NUCLEAR INDUSTRY, 1st (Sao Paulo: ABEN, 2009, 2014)

Radiolabeling of substance P with lutetium-177 and biodistribution study in AR42J pancreatic tumor xenografted Nude mice

ARAUJO, ELAINE B.; PUJATTI, PRISCILLA B.; BARRIO, OFELIA; CALDEIRA, JOSE S.; SUZUKI, MIRIAM F.; MENGATTI, JAIR; SIMPOSIO DE DOSIMETRIA INTERNA APLICADA A MEDICINE NUCLEAR, 1. (2014)

1
2
3
4
. . .
8

Buscar

Filtros

Development of a new bombesin analog radiolabelled with lutetium-177: in vivo evaluation of the biological properties in BALB-C mice

Radiolabeling of substance p with lutetium-177 and biodistribution study in rat pancreatic tumor xenografted nude mice

On the feasibility of producing Lu-177 in the IEA-R1 reactor via the direct route

On the feasibility of producing Lu-177 in the IEA-R1 reactor via the direct route

Radiolabeling of anti-cd20 with Re-188: liquid kit

Lutetium 177-DOTA-TATE therapy for esthesioneuroblastoma: A case report

In vitro and in vivo response of PSMA-617 radiolabeled with CA and NCA lutetium-177

In vitro response of 177Lu-PSMA-617 with two different specific activities

Study of the radiolabeling of substance P with lutetium 177 and analysis of the stability In Vitro: development of new radiopharmaceutical for tumor treatment

Radiolabeling of substance P with lutetium-177 and biodistribution study in AR42J pancreatic tumor xenografted Nude mice